13
Total investments
1
Early stage
0
Mid stage
2
Late stage
41y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2020
Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques.
Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine.
Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient.
Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education.
Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 50 countries.
Board Member
Dec 2017
QuantuMDx is a progressive MedTech company passionate empowering the world to control disease and reduce suffering. QuantuMDx solve real-world problems by creating multiplex molecular diagnostic solutions for the point of need, for anyone, anywhere.
We at QuantuMDx have always believed life for people around the world can be improved if they have better access to the highest quality testing when and where they need it. Life is better in so many ways when we can diagnose at the point of need. It’s easier, more efficient, with less time, cost and anxiety. Transmission is slowed and ultimately people suffer less.
Multiplex molecular diagnostics provides this thorough solution at the point of need. We realize the point of need is different in every situation – and diagnostics should be available to everybody when they need it.
Member of the board
Sep 2012
Headquartered in San Francisco, WellnessFX™ is dedicated to putting health in the hands of the consumer. At the forefront of the consumer health revolution, WellnessFX’s digital medical marketplace offers an accessible, streamlined way to collect, interpret, and track personal health data. WellnessFX aggregates the underlying biomarkers of common conditions such as cardiovascular disease, diabetes, metabolic syndrome, and thyroid imbalance, and then provides actionable solutions. Data is communicated through rich, personalized visualizations and delivered via a sleek interface to bring healthcare into the 21st century. For more information, go to: http://www.wellnessfx.com.
Member of the board and co-fouder
Dec 2011
With 7 centers, Sinomedica is Switzerland’s leading provider of results-driven medical acupuncture and one of the largest in Europe. We are looking for talented and qualified medical acupuncturists and TCM specialists to join our growing team in Bern, Basel, Zurich, Lucerne, Geneva, and Lausanne and more location to follow in the near future.
Sinomedica offers an innovative, science-based, patient-centered, effective, risk-free, painless and integrative therapeutic approach.
Based on one of the largest clinical databases of acupuncture treatments in Europe and the expertise of highly qualified practitioners specialized in both conventional medicine and in acupuncture, Sinomedica combines its treatments with the latest scientific findings.
Member of the Board
Apr 2011
We’re a team of dreamers, scientists, doctors, and health enthusiasts – all working toward the same goal – helping every individual discover and achieve their best possible health. We do it by creating innovative health solutions and by owning every process, from R&D to product delivery and customer service. We intend to defy expectations of good health through home testing technology, dietary and lifestyle education, and superior nutritional products.
From its early beginnings, Thorne has grown from just being a practitioner-trusted brand to one of the fastest growing D-to-C health product providers in the industry – earning trusted partnerships with UFC, MLB, NBA, and NFL athletes, as well as multiple U.S. National Teams along the way. Through our products and services, our passionate, talented staff, collaboration with a variety of innovative and expert strategic partners, and an unwavering commitment to integrity, we have evolved into a global health solutions provider – because good health knows no boundaries.
The key to our success is a user-centric approach that always puts the individual at the center of our operations. From our distinguished researchers to our elite customer-care team, every individual at Thorne has a first-hand opportunity to make a difference.
We are always looking for new ways to innovate, and there is plenty of room for you to leave your mark here. If you’re an individual that embraces challenge, fosters innovation, and desires to make a difference in the world – then join us.
Member of the Board
Apr 2011
Thorne HealthTech is a leader in developing the world’s most innovative solutions for a personalized approach to health and well-being through our vertically integrated brand Thorne. As a science-driven wellness company that empowers individuals with the support, education, and solutions they need to achieve healthy aging – living healthier and longer – we utilize testing and data to create improved product efficacy and to deliver personalized solutions to consumers, health professionals, and corporations. Predicated on the power of the individual, Thorne HealthTech leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime.
We are trusted by more than four million customers, 45,000 health professionals, thousands of professional athletes, more than 100 professional sports teams, and 11 U.S. National teams and are proud to be the only supplement manufacturer that collaborates with Mayo Clinic on wellness research and content.
The Thorne HealthTech team consists of a people from diverse backgrounds, united under a common cause. We are expanding the frontiers of health, technology, and science – and invite you to be a part of our mission.
Member of the Board
Jan 1985
Welcome to Helsinn’s LinkedIn page.
This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional
Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer supportive care and an innovative pipeline of cancer therapeutics.
Helsinn is a third-generation family-owned company, that since 1976 has been focused on improving the lives of patients, guided by core values of respect, integrity and quality. It operates a unique licensing business model with integrated drug development and manufacturing capabilities. Helsinn has a commercial presence in 190 countries either directly, with operating subsidiaries in the U.S. and China, or via its long-standing trusted partners. Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd.
If you are interested in joining Helsinn or one of our affiliates, please visit helsinn.com. Applications should only be submitted via the appropriate country portal under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact: Switzerland: info-HHC@helsinn.com, U.S.: HTU-HR@helsinn.com, Ireland: info-hbp@helsinn.com. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED]
Experience · 16 entries
All (16)
Investments (13)
Founder (2)
Board (13)
2023
F
Fondazione Helmut Horten
Board Member
Dec 2023
2020
Board Member
Dec 2020
Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques.
Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine.
Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient.
Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education.
Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 50 countries.
2019
Member of the Board
Jan 2019
ASCO’s foundation funding research to conquer every cancer, for every patient, everywhere.
Our Mission: Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer.
Our Vision: A world where cancer is prevented or cured, and every survivor is healthy.
2017
Board Member
Dec 2017
QuantuMDx is a progressive MedTech company passionate empowering the world to control disease and reduce suffering. QuantuMDx solve real-world problems by creating multiplex molecular diagnostic solutions for the point of need, for anyone, anywhere.
We at QuantuMDx have always believed life for people around the world can be improved if they have better access to the highest quality testing when and where they need it. Life is better in so many ways when we can diagnose at the point of need. It’s easier, more efficient, with less time, cost and anxiety. Transmission is slowed and ultimately people suffer less.
Multiplex molecular diagnostics provides this thorough solution at the point of need. We realize the point of need is different in every situation – and diagnostics should be available to everybody when they need it.
G
Greenbone Ortho S.r.l.
Board Member
Jun 2017
Show all 16 entries ↓
Investment activity
1985–2023 · 13 investments
Recent (last 2 years)Earlier